Evidence map›Paper›PMID 38936926›Full record

ArticleIn vivo (Athens, Greece)

Robotic

Tatsuki Watanabe, Kazuhito Sasaki, Hiroaki Nozawa, Koji Murono, Shigenobu Emoto, Hiroyuki Matsuzaki, Yuichiro Yokoyama, Shinya Abe, Yuzo Nagai, Takahide Shinagawa and 3 more

Abstract readComparative Study
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tatsuki WatanabeDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Kazuhito SasakiDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan sasakik-sur@h.u-tokyo.ac.jp.
Hiroaki NozawaDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Koji MuronoDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Shigenobu EmotoDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroyuki MatsuzakiDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Yuichiro YokoyamaDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Shinya AbeDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Yuzo NagaiDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Takahide ShinagawaDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Hirofumi SonodaDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Lim SukcholDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Soichiro IshiharaDepartment of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimThe usefulness of robotic surgery compared to laparoscopic surgery for rectal cancer has been reported; however, few reports exist on robotic abdominoperineal resection (APR). The aim of this study was to compare the outcomes of robotic and laparoscopic surgery to determine their usefulness in patients with locally advanced rectal cancer who had undergone preoperative chemoradiotherapy (CRT). PATIENTS AND

methodsThis retrospective study included 43 patients with locally advanced rectal cancer who underwent preoperative CRT and robotic (22 patients) or laparoscopic APR (21 patients) between December 2012 and September 2022. We examined the short- and long-term outcomes in the robotic and laparoscopic groups.

resultsThe median follow-up durations were 36 and 48 months for the robotic and laparoscopic groups, respectively. No significant differences in operative time, intraoperative blood loss, or overall complication rates were observed. However, the incidence of organ/space surgical site infection (SSI) was significantly lower in the robotic surgery group than in the laparoscopic group (9.1% vs. 38.1%, p=0.034) and the 3-year overall survival rate was significantly higher in the robotic surgery group than in the laparoscopic group (95% vs. 67%, p=0.029).

conclusionRobotic APR was associated with a significantly lower rate of organ/space SSIs than the laparoscopic approach, indicating the usefulness of the robotic approach.

Indexed as

ChemoradiotherapyLaparoscopyRectal NeoplasmsRobotic Surgical ProceduresAdultAgedFemaleHumansMaleMiddle AgedNeoplasm StagingProctectomyRetrospective StudiesTreatment OutcomeAbdominoperineal resectionlaparoscopic surgeryorgan/space surgical site infectionpreoperative chemoradiotherapyrobotic surgery

Identifiers

PMID38936926
PMCPMC11215614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.